IberiaBank’s Novartis NVS Stock Holding History

IberiaBank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.12M	Sell	12,841 -201	-2%	-$17.4K	0.13%	121
2020 Q1	$1.07M	Buy	13,042 +312	+2%	+$27.8K	0.14%	112
2019 Q4	$1.21M	Sell	12,730 -200	-2%	-$17.9K	0.13%	116
2019 Q3	$1.12M	Sell	12,930 -255	-2%	-$22.9K	0.13%	116
2019 Q2	$1.2M	Sell	13,185 -1,653	-11%	-$140K	0.13%	122
2019 Q1	$1.28M	Sell	14,838 -2,652	-15%	-$213K	0.15%	121
2018 Q4	$1.34M	Sell	17,490 -1,363	-7%	-$106K	0.17%	115
2018 Q3	$1.46M	Buy	18,853 +3,514	+23%	+$260K	0.18%	128
2018 Q2	$1.04M	Sell	15,339 -754	-5%	-$52K	0.18%	130
2018 Q1	$1.17M	Buy	16,093 +64	+0.4%	+$4.87K	0.23%	124
2017 Q4	$1.21M	Buy	16,029 +1,491	+10%	+$112K	0.19%	131
2017 Q3	$1.12M	Buy	+14,538	New	+$1.1M	0.19%	130
2016 Q1	–	Sell	-2,953	Closed	-$228K	–	171
2015 Q4	$228K	Buy	2,953 +159	+6%	+$12.6K	0.1%	145
2015 Q3	$230K	Buy	2,794 +12	+0.4%	+$1.07K	0.12%	137
2015 Q2	$245K	Buy	2,782 +119	+4%	+$10.9K	0.11%	154
2015 Q1	$235K	Buy	+2,663	New	+$236K	0.11%	167
2014 Q3	–	Sell	-2,588	Closed	-$210K	–	177
2014 Q2	$210K	Buy	+2,588	New	+$204K	0.12%	174

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

IberiaBank's NVS Position: Q2 2020 in Review

IberiaBank reduced its Novartis (NVS) stake by 1.5% in Q2 2020, selling an estimated $17.4K and leaving 12,841 shares worth $1.12M. The position accounts for 0.13% of the portfolio, ranked #121.

IberiaBank first reported a position in NVS in Q2 2014 and has held it in 17 quarters since. The position peaked at $1.46M in Q3 2018. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

IberiaBank held 12,841 shares of Novartis worth $1.12M as of Q2 2020.
IberiaBank sold 201 Novartis shares in Q2 2020, an estimated $17.4K.
Novartis made up 0.13% of IberiaBank's portfolio in Q2 2020, its #121 holding.
IberiaBank first reported a position in Novartis in Q2 2014 and has held it in 17 quarters since.
IberiaBank's Novartis position peaked at $1.46M in Q3 2018.
1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.